<DOC>
	<DOCNO>NCT01717287</DOCNO>
	<brief_summary>This multicenter , open-label , noncomparative study evaluate two oral formulation raltegravir ( MK-0518 , film-coated tablet chewable tablet ) combination antiretroviral agent safety , tolerability , antiretroviral activity treatment-naive treatment-experienced Russian child adolescent infected human immunodeficiency virus-1 ( HIV-1 ) . As raltegravir indicate combination antiretroviral therapy ( ARTs ) treatment HIV-1 infection pediatric patient United States ( US ) , study design gain local treatment experience use raltegravir pediatric HIV-infected population Russia .</brief_summary>
	<brief_title>A Study Safety , Tolerability , Antiretroviral Activity Raltegravir ( MK-0518 ) Combination With Other Antiretroviral Therapies Russian Children Adolescents Infected With Human Immunodeficiency Virus ( HIV-1 ) ( MK-0518-248 )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Anti-Retroviral Agents</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>HIV positive Weight least 7 kg HIV RNA â‰¥1000 copies/mL within 45 day study treatment Participants reproductive potential sexually active agree remain abstinent use ( partner use ) acceptable method birth control throughout study . Females pregnant breastfeeding , expect conceive donate egg study ; male plan impregnate provide sperm donation study Use nonantiretroviral ( ART ) investigational agent within one month study treatment Current ( active ) diagnosis acute hepatitis chronic hepatitis stable chronic Hepatitis B and/or C Prior current use raltegravir Use another experimental HIVintegrase inhibitor History current evidence condition , therapy , laboratory abnormality , circumstance might confound result study , interfere participation full duration study Requires anticipate require prohibit medication Use immunosuppressive therapy within 30 day begin raltegravir study treatment ; short course corticosteroid permit . History malignancy Current treatment active tuberculosis infection Use recreational illicit drug recent history ( within last year ) drug alcohol abuse dependence</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>